top of page
Executive Spotlights

Harmony Biosciences (HRMY) Appoints Jeffrey M. Dayno as President and CEO

Montgomery County, PA, April 24, 2023 (StreetInsider) -- Harmony Biosciences Holdings, Inc., a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that Jeffrey M. Dayno, M.D., has been appointed President and Chief Executive Officer by the Company's Board of Directors and has been elected to join as a member of the Board.

Read full article here.

Recent Posts

See All


Life Science Headlines
bottom of page